Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion?

Carpagnano GE, Costantino E, Palladino GP, Lacedonia D, Martinelli D, Orlando S, Foschino-Barbaro MP.

Rejuvenation Res. 2012 Jun;15(3):265-73. doi: 10.1089/rej.2011.1260. Epub 2012 May 2.

PMID:
22551519
2.

Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions.

Economidou F, Tzortzaki EG, Schiza S, Antoniou KM, Neofytou E, Zervou M, Lambiri I, Siafakas NM.

Oncol Rep. 2007 Dec;18(6):1507-12.

PMID:
17982637
4.

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.

Sriram KB, Relan V, Clarke BE, Duhig EE, Windsor MN, Matar KS, Naidoo R, Passmore L, McCaul E, Courtney D, Yang IA, Bowman RV, Fong KM.

BMC Cancer. 2012 Sep 25;12:428. doi: 10.1186/1471-2407-12-428.

5.

Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.

Rodríguez de Castro F, Molero T, Acosta O, Julià-Serdà G, Caminero J, Cabrera P, Carrillo T.

Thorax. 1994 Jul;49(7):692-4.

6.

Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.

Han J, Cao S, Zhang K, Zhao G, Xin Y, Dong Q, Yan Y, Cui J.

J Cardiothorac Surg. 2012 Nov 13;7:121. doi: 10.1186/1749-8090-7-121.

7.

Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology.

Woenckhaus M, Grepmeier U, Werner B, Schulz C, Rockmann F, Wild PJ, Röckelein G, Blaszyk H, Schuierer M, Hofstaedter F, Hartmann A, Dietmaier W.

J Mol Diagn. 2005 Oct;7(4):517-24.

8.
9.

Calprotectin: a novel biomarker for the diagnosis of pleural effusion.

Sánchez-Otero N, Blanco-Prieto S, Páez de la Cadena M, Vázquez-Iglesias L, Fernández-Villar A, Botana-Rial MI, Rodríguez-Berrocal FJ.

Br J Cancer. 2012 Nov 20;107(11):1876-82. doi: 10.1038/bjc.2012.478. Epub 2012 Oct 23.

10.

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.

Dietrich D, Jung M, Puetzer S, Leisse A, Holmes EE, Meller S, Uhl B, Schatz P, Ivascu C, Kristiansen G.

PLoS One. 2013 Dec 27;8(12):e84225. doi: 10.1371/journal.pone.0084225. eCollection 2013.

11.

Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.

Benlloch S, Galbis-Caravajal JM, Martín C, Sanchez-Paya J, Rodríguez-Paniagua JM, Romero S, Mafe JJ, Massutí B.

Cancer. 2006 Oct 15;107(8):1859-65.

12.

[Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].

Wang LX, Chen WX, Wu J, Chen SX, Huang XY, Chen YF.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Dec;29(12):804-7. Chinese.

PMID:
17327081
13.

Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion.

Radjenovic-Petkovic T, Pejcic T, Nastasijević-Borovac D, Rancic M, Radojkovic D, Radojkovic M, Djordjevic I.

Med Arh. 2009;63(3):141-2.

PMID:
20088159
14.

Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion.

Li J, Bao QL, Wang Y, Hu YM, Chen P.

Cancer Biomark. 2013;13(1):49-58. doi: 10.3233/CBM-130319.

PMID:
23736021
15.

The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.

Fiorelli A, Morgillo F, Fasano M, Vicidomini G, Di Crescenzo VG, Di Domenico M, Accardo M, Santini M.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):263-9. doi: 10.1093/icvts/ivs466. Epub 2012 Nov 28.

16.
17.

Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions.

Rosolen DC, Kulikowski LD, Bottura G, Nascimento AM, Acencio M, Teixeira L, Vargas FS, Sales RK, Antonangelo L.

Lung Cancer. 2013 Jun;80(3):284-8. doi: 10.1016/j.lungcan.2013.02.001. Epub 2013 Feb 28.

PMID:
23453645
19.

[Accuracy of pleural fluid cytology in malignant effusions].

Bielsa S, Panadés MJ, Egido R, Rue M, Salud A, Matías-Guiu X, Rodríguez-Panadero F, Porcel JM.

An Med Interna. 2008 Apr;25(4):173-7. Spanish.

20.

Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?

Brock MV, Hooker CM, Yung R, Guo M, Han Y, Ames SE, Chang D, Yang SC, Mason D, Sussman M, Baylin SB, Herman JG.

Ann Thorac Surg. 2005 Oct;80(4):1241-7.

PMID:
16181847

Supplemental Content

Support Center